{"id":4717,"date":"2025-09-04T15:35:38","date_gmt":"2025-09-04T13:35:38","guid":{"rendered":"https:\/\/blog.molport.com\/?p=4717"},"modified":"2025-09-02T08:27:44","modified_gmt":"2025-09-02T06:27:44","slug":"molport-chronicles-from-alchemy-to-pharma-4","status":"publish","type":"post","link":"https:\/\/blog.molport.com\/news\/molport-chronicles-from-alchemy-to-pharma-4\/","title":{"rendered":"Molport Chronicles- from Alchemy to Pharma No. 4"},"content":{"rendered":"

From Apothecary to Alkaloid Pioneer: <\/span>The Origins of Merck and Modern Drug Discovery<\/span><\/h2>\n

Did you know that Merck, one of the oldest pharmaceutical companies in the world, played a foundational role in the development of alkaloid chemistry, laying the groundwork for modern medicinal chemistry and compound screening?<\/span>\u00a0<\/span><\/p>\n

The story begins in 1668, when Friedrich Jacob Merck<\/a> purchased the Engel-Apotheke (Angel Pharmacy) in Darmstadt, Germany. However, the real transformation occurred in 1827, when Heinrich Emanuel Merc<\/a>k transformed the family pharmacy into a chemical-pharmaceutical enterprise focused on isolating pure alkaloids from natural sources \u2014a revolutionary approach at the time.<\/span>\u00a0<\/span><\/p>\n

One of the most critical early breakthroughs was the isolation and commercialization of morphine, a milestone in the history of medicine. For the first time, physicians had access to a standardized, potent treatment for moderate to severe pain, which changed the landscape of therapeutic care.<\/span>\u00a0<\/span><\/p>\n

Interestingly, Heinrich Emanuel Merck maintained a collection of purified alkaloids, essentially a curated set of bioactive molecules, which served as an \u201cearly precursor to the compound libraries\u201d used in modern high-throughput screening for drug discovery. This was far ahead of its time.<\/span>\u00a0<\/span><\/p>\n

Over the decades, Merck\u2019s work expanded to include codeine, cocaine (then used as anaesthetics), and other natural product derivatives. This positioned Merck as a true pioneer in turning plant-derived chemistry into scalable, pharmaceutically relevant compounds.<\/span>\u00a0<\/span><\/p>\n

While today the discussion around opioids often focuses on their potential for abuse, and rightfully so, it\u2019s essential also to recognize their critical role in pain management. When used responsibly and under medical supervision, opioid-based treatments remain among the most effective tools for relieving suffering, especially in surgical, oncological, and palliative care settings.<\/span>\u00a0<\/span><\/p>\n

Merck’s legacy continues today through Merck KGaA (Germany) and Merck & Co. (USA) \u2014 two globally recognized entities born from this early vision of transforming chemistry into healing.<\/span>\u00a0<\/span><\/p>\n

Interested in alkaloids for drug discovery projects? You are welcome to download our NP set.<\/a><\/span><\/p>\n

\"Molport<\/p>\n

Other Molport Chronicles posts- from Alchemy to Pharma:<\/p>\n